Insider Transactions in Q4 2022 at Theravance Biopharma, Inc. (TBPH)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2022
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
50,000
-3.57%
|
$550,000
$11.19 P/Share
|
|
Dec 13
2022
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
SELL
Bona fide gift
|
Direct |
9,000
-0.64%
|
-
|
|
Dec 01
2022
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
2,084
-0.66%
|
$20,840
$10.73 P/Share
|
|
Nov 22
2022
|
Donal O'Connor |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,000
-18.56%
|
$100,000
$10.5 P/Share
|
|
Nov 20
2022
|
Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS |
SELL
Payment of exercise price or tax liability
|
Direct |
23,268
-7.28%
|
$232,680
$10.85 P/Share
|
|
Nov 20
2022
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
SELL
Payment of exercise price or tax liability
|
Direct |
27,350
-7.97%
|
$273,500
$10.85 P/Share
|
|
Nov 20
2022
|
Andrew A. Hindman SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
25,057
-6.11%
|
$250,570
$10.85 P/Share
|
|
Nov 20
2022
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
15,804
-1.11%
|
$158,040
$10.85 P/Share
|
|
Nov 18
2022
|
Andrew A. Hindman SVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
65,000
-13.69%
|
$715,000
$11.02 P/Share
|
|
Nov 16
2022
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
SELL
Payment of exercise price or tax liability
|
Direct |
2,800
-0.81%
|
$30,800
$11.2 P/Share
|